| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $69.8M | +71.5% |
| Cost of Revenue | $142.5M | +41.1% |
| Gross Profit | -$72.7M | -20.6% |
| R&D Expense | $262.2M | +41.5% |
| SG&A Expense | $159.8M | +1.0% |
| Operating Income | -$563.3M | -27.3% |
| Interest Expense | $11.0M | -0.4% |
| Pre-tax Income | -$569.6M | -27.9% |
| Income Tax | $1.7M | +152.4% |
| Net Income | -$571.3M | -28.1% |
| EPS (Basic) | -$1.47 | -17.6% |
| EPS (Diluted) | -$1.47 | -17.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $139.1M | +100.0% |
| Accounts Receivable | $14.1M | +26.4% |
| Inventory | $12.2M | +38.7% |
| Current Assets | $350.6M | -36.8% |
| Total Assets | $512.4M | -25.5% |
| Current Liabilities | $83.9M | +8.2% |
| Total Liabilities | $737.1M | +3.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$247.3M | -18.8% |
| Capital Expenditures | $21.9M | +40.4% |
| Investing Cash Flow | $236.6M | +745.5% |
| Financing Cash Flow | $80.2M | +201.1% |
| Free Cash Flow | -$269.2M | -20.3% |
| Stockholders' Equity |
| -$224.7M |
| -751.2% |